α-硫辛酸对终末期肾脏疾病患者晚期氧化蛋白产物的影响

来源 :医学临床研究 | 被引量 : 0次 | 上传用户:hionor
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
【目的】研究α-硫辛酸对终末期肾脏疾病(ES RD )患者晚期氧化蛋白产物的影响,探讨其可能的保护作用。【方法】将在本院进行维持性血液透析或腹膜透析的ES RD患者共45例,随机分为三组,每组15例,A组为α-硫辛酸治疗组,B组为维生素E治疗组,C组为常规治疗组。另外选取本院健康体检者15例为正常对照组(N组)。治疗前及各组治疗半个月后,抽血监测血浆氧化应激指标晚期氧化蛋白产物(AOPP )、超氧化物歧化酶(SOD)并进行比较。【结果】治疗前A、B、C三组患者血浆AOPP含量均高于N组,SOD含量均低于N组,且与N组相比较差异均有显著性(均 P <0.01),而 A、B、C三组之间 AOPP、SOD含量相比较差异均无显著性( P >0.05)。治疗后A、B组AOPP含量较治疗前均有所下降,且与治疗前相比差异均有显著性( P<0.05),与B组比较,A组AOPP含量下降更为明显,且差异有显著性( P <0.01)。而A、B组SOD含量较治疗前均有所升高,且与治疗前相比差异均有显著性( P <0.05),与B组比较,A 组SOD含量升高更明显,且差异有显著性( P <0.01)。C组患者AOPP、SOD含量与治疗前相比较差异均无显著性( P >0.05)。【结论】α-硫辛酸能降低ESRD患者氧化应激水平,且疗效优于使用维生素E治疗组。“,”[Objective] To study the effect of α-lipoic acid on advanced oxidation protein products in patients with chronic kidney disease(ESRD) ,and to explore the possible protective role .[Methods] Forty-five patients with ERSD undergoing hemodialysis or peritoneal dialysis were randomly divided into three groups with 15 patients in each group .Group A was treated with α-lipoic acid ,and group B was treated with vitamin E ,and group C re-ceived conventional treatment .In addition ,15 healthy subjects in our hospital were recruited as normal control group(group N) .The oxidative stress indicators such as advanced oxidation protein products (AOPP) and super-oxide dismutase(SOD) before and half a month after treatment were measured and compared .[Results] Before treatment ,AOPP level in plasma of group A ,B and C was higher than that of group N ,while SOD level was low-er than that of group N ,and there was significant difference between group A ,B or C and group N(all P<0 .01) . There was no significant difference in AOPP and SOD levels among group A ,B and C .Compared with before treatment ,AOPP level in group A and group after treatment were decreased ,and there was significant difference between before and after treatment ( P <0 .05) .Compared with group B ,AOPP level in group A was decreased more significantly ,and there was significant difference( P<0 .01) ,while SOD level in group A and group B were increased ,and there was significant difference between before and after treatment ( P < 0 .05) .Compared with group B ,SOD level in group A was increased more significantly ,and there was significant difference( P0 .05) .[Conclusion] Theα-lipoic acid can reduce the level of oxidative stress in ESRD patients ,and its efficacy is better than vitamin E .
其他文献
【目的】观察腹腔镜与胆道镜联合应用治疗胆总管结石的临床疗效。【方法】120例胆总管结石需行手术治疗患者,随机分为两组,每组60例,试验组采取双镜联合取石,对照组采取开腹手术
【目的】探讨白介素-1β(interleukin-1β,IL-1β)基因rs1143627-C/T 多态性与2型糖尿病(T2DM )的关系。【方法】应用MassARRAY分子量阵列技术检测240例 T2DM 患者(DM 组)和245例健
【目的】探讨半导体激光联合赛肤润治疗静脉留置针所致静脉炎的效果。【方法】将本院因静脉留置针所致静脉炎患者80例按随机数字表法分为试验组和对照组,每组各40例。试验组在
【目的】探讨高血压病患者颈动脉粥样硬化与脉压(PP)和脉压指数(PPI)的相关性。【方法】选取高血压患者162例,所有患者采用彩色多普勒超声测定颈动脉内中膜厚度(IM T ),并依据IM T分
【目的】了解高校大学生性与生殖健康知识知晓情况,探索在高校大学生中开展生殖健康教育的有效模式。【方法】采用自行设计的调查表,随机抽取某高校506名年龄为16~22岁的一至四
【目的】调查和分析中年男性高脂血症患者伴发高同型半胱氨酸(Hcy )血症、高铁蛋白(Ferr )血症、高尿酸(U A )血症发生情况。【方法】选取本院40~60岁男性高脂血症患者和同年龄段血
【目的】探讨仿生物理治疗女性轻、中度压力性尿失禁(SUI)的疗程及疗效。【方法】来本院就诊的SUI患者93例,其中轻度组62例,根据治疗意愿分为轻度1组31例,轻度2组31例;中度组31例。
【目的】探讨应用吡拉西坦氯化钠注射液治疗脑出血患者的临床效果。【方法】选择本院2010年8月至2012年8月间进行诊治的120例脑出血患者,将其随机分为两组,试验组的60例患者应
【目的】探讨氨磺必利治疗精神分裂症的临床疗效与安全性。【方法】121例精神分裂症患者随机分为氨磺必利组(N=61)与奥氮平组(N=60)两组,分别予以氨磺必利与奥氮平治疗,疗程12周。采
【目的】探讨生物反馈电刺激联合阴道哑铃对子宫全切术后患者盆底功能恢复的疗效。【方法】160例行开腹子宫全切术后患者分为四组,每组40例,A组给予kegel训练,B组给予阴道哑铃训